Could ivabradine be a new treatment for the short QT syndrome? - Wikidata - awgldk - TriplyDB

Could ivabradine be a new treatment for the short QT syndrome?

Could ivabradine be a new treatment for the short QT syndrome?

http://www.wikidata.org/entity/Q53202908

about

Could ivabradine be a new treatment for the short QT syndrome?

http://www.wikidata.org/entity/Q53202908

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Could ivabradine be a new treatment for the short QT syndrome?

@en

Could ivabradine be a new treatment for the short QT syndrome?

@nl

type

label

Could ivabradine be a new treatment for the short QT syndrome?

@en

Could ivabradine be a new treatment for the short QT syndrome?

@nl

prefLabel

Could ivabradine be a new treatment for the short QT syndrome?

@en

Could ivabradine be a new treatment for the short QT syndrome?

@nl

P1433

Q53202908-9707B4DA-427A-4371-B5FB-D269933F0446

P1476

Q53202908-212C274B-57BC-4A01-AB18-45E7140185F7

P2093

Q53202908-B2D776CF-0BA4-45E2-BFE0-B73FE0F9039B

P2860

Q53202908-1F6651CE-3D12-41CF-BC47-77833B846023

Q53202908-3CC391BC-C2A5-4DE0-B5CC-FB2A84737219

Q53202908-5C5D7F49-B4D5-47DA-B818-8898304B75CB

Q53202908-60E3AADD-DB67-4526-A6E3-305FBEE32294

Q53202908-97F12B78-DE0B-439F-806B-0F3AFEA7D64E

Q53202908-B80164DA-3CC8-4FD3-A35D-AB036FAF9E5C

Q53202908-C5895A0D-D99C-4202-A646-23DBF66EB2BC

Q53202908-C6F5C443-4675-4B98-BFD8-708A92C28998

Q53202908-C8F94E3A-0B7F-4E03-9D59-53CDDB007BA9

Q53202908-E25DB65D-5099-47D3-8030-328DA6774236

P304

Q53202908-34027F05-2877-43FB-A686-A7FF035F451F

P31

Q53202908-323CB687-6100-4106-A4C3-7B55E7506E32

Q53202908-4689e751-7e38-4b2f-ae76-e3f4491f53d5

P356

Q53202908-58BA8BA2-0B70-46A2-9996-39E4916F4883

P433

Q53202908-1AA9942C-FE8C-445C-9360-DB653170A086

P478

Q53202908-03046A9D-B1F5-4D8A-805D-2827C7E04FF0

P577

Q53202908-AA92FF46-B029-4188-BB3E-2192FA5528F4

P698

Q53202908-E7FAC300-82C1-4CF0-826E-D792FE5F6B0F

P356

1440-1681.12802

P1433

Clinical and Experimental Pharmacology and Physiology

P1476

Could ivabradine be a new treatment for the short QT syndrome?

@en

P2093

Jules C Hancox

http://www.w3.org/2001/XMLSchema#string

P2860

Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.

Long-term follow-up of patients with short QT syndrome.

Short QT syndrome: from bench to bedside.

Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome

hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.

Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure.

Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4.

Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.

Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome.

P304

907-908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12802

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28640933

http://www.w3.org/2001/XMLSchema#string